BXRX
Baudax Bio, Inc. Common Stock
BXRX
BXRX
Delisted
BXRX was delisted on the 15th of November, 2023.
31 hedge funds and large institutions have $9.43M invested in Baudax Bio, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
23% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 13
Holders
31
Holding in Top 10
–
Calls
$899K
Puts
$105K
Top Buyers
| 1 | +$4.38M | |
| 2 | +$1.64M | |
| 3 | +$433K | |
| 4 |
Two Sigma Advisers
New York
|
+$171K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$135K |
Top Sellers
| 1 | -$3.54M | |
| 2 | -$426K | |
| 3 | -$268K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$181K |
| 5 |
D.E. Shaw & Co
New York
|
-$134K |